Table 1 Phase I study of DC-based therapy against high-grade glioma
Patient no. | Age | Sex | Previous therapy | PS | Pathological diagnosis (WHO grade) |
|---|---|---|---|---|---|
1 | 69 | M | ST, CT | 1 | GBM (IV) |
2 | 49 | M | ST, CT, RT | 0 | AO (III) |
3 | 38 | M | ST, CT, RT | 2 | GBM (IV) |
4 | 32 | F | CT, RT, | 2 | AA (III) |
5 | 61 | M | ST, CT, RT | 1 | GBM (IV) |
6 | 32 | M | ST, CT, RT | 1 | GBM (IV) |
7 | 73 | M | ST, CT, RT | 1 | GBM (IV) |
8 | 53 | F | ST, CT, | 1 | GBM (IV) |
9 | 31 | M | ST, CT, | 1 | GBM (IV) |